Jacobs Levy Equity Management
VYGR icon

Jacobs Levy Equity Management’s Voyager Therapeutics VYGR Stock Holding History

Jacobs Levy Equity Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27,046
Closed -$84.1K – 1128
2025
Q2 		$84.1K Sell
27,046
-37,478
-58% -$121K ﹤0.01% 1011
2025
Q1 		$218K Buy
+64,524
New +$301K ﹤0.01% 1021
2021
Q4 		– Sell
-438,767
Closed -$1.15M – 1083
2021
Q3 		$1.15M Sell
438,767
-16,896
-4% -$54.9K 0.01% 726
2021
Q2 		$1.88M Sell
455,663
-106,006
-19% -$480K 0.01% 614
2021
Q1 		$2.65M Buy
561,669
+452,885
+416% +$3.09M 0.02% 540
2020
Q4 		$778K Buy
108,784
+25,239
+30% +$243K 0.01% 773
2020
Q3 		$891K Buy
83,545
+20,419
+32% +$240K 0.01% 685
2020
Q2 		$797K Buy
63,126
+48,225
+324% +$561K 0.01% 718
2020
Q1 		$136K Buy
14,901
+2,391
+19% +$27.4K ﹤0.01% 934
2019
Q4 		$175K Sell
12,510
-35,120
-74% -$510K ﹤0.01% 949
2019
Q3 		$820K Buy
47,630
+17,690
+59% +$371K 0.01% 647
2019
Q2 		$815K Sell
29,940
-28,205
-49% -$645K 0.01% 678
2019
Q1 		$1.11M Buy
+58,145
New +$757K 0.02% 633
2018
Q3 		– Sell
-13,300
Closed -$260K – 1082
2018
Q2 		$260K Buy
+13,300
New +$263K ﹤0.01% 915

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jacobs Levy Equity Management's VYGR Position: Q3 2025 in Review

Jacobs Levy Equity Management sold out of Voyager Therapeutics (VYGR) in Q3 2025, closing a stake of 27,046 shares — an estimated $84.1K sold.

Jacobs Levy Equity Management first reported a position in VYGR in Q2 2018 and held it in 14 quarters. The position peaked at $2.65M in Q1 2021. 117 funds tracked by Wall St. Rank hold VYGR as of Q3 2025.

  • Jacobs Levy Equity Management reported no remaining Voyager Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 27,046 Voyager Therapeutics shares in Q3 2025, an estimated $84.1K.
  • Jacobs Levy Equity Management first reported a position in Voyager Therapeutics in Q2 2018 and held it in 14 quarters.
  • Jacobs Levy Equity Management's Voyager Therapeutics position peaked at $2.65M in Q1 2021.
  • 117 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2025.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.